Healthcare Finance News January 16, 2025
Jeff Lagasse

CEO Andrew Witty promises to pass through 100% of drug rebates to consumers and wants see other companies do the same.

UnitedHealth Group’s 2024 revenues hit $400.3 billion in 2024 – a 6% year-over-year increase – and full-year earnings from operations were $32.3 billion.

CEO Andrew Witty attributed much of this performance to a strong showing from pharmacy benefit manager OptumRx.

“Pharmacy benefit managers play a vital role in keeping those prices down,” said Witty during Thursday’s Q4 earnings call. “OptumRx alone delivers tens of billions of dollars in savings annually.”

During the call, Witty promised to pass through 100% of drug rebates to consumers and said he wants to see other companies do the same. UnitedHealth currently passes through...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer
It’s Time for Health Plans to Hold Behavioral Health Providers Accountable for Outcomes
Why 'intellectual curiosity' is key for payer CEOs
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
Where 14 payers are growing in 2025

Share This Article